Sequoia Financial Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-214,949
Closed -$25.8K 1486
2024
Q4
$25.8K Hold
214,949
﹤0.01% 1333
2024
Q3
$29.5K Hold
214,949
﹤0.01% 1274
2024
Q2
$31.4K Hold
214,949
﹤0.01% 1202
2024
Q1
$31.4K Hold
214,949
﹤0.01% 1147
2023
Q4
$43K Buy
+214,949
New +$37.8K ﹤0.01% 1181
2022
Q3
Sell
-15,000
Closed -$3K 607
2022
Q2
$3K Hold
15,000
﹤0.01% 592
2022
Q1
$5K Hold
15,000
﹤0.01% 670
2021
Q4
$5K Hold
15,000
﹤0.01% 594
2021
Q3
$8K Hold
15,000
﹤0.01% 257
2021
Q2
$12K Hold
15,000
﹤0.01% 476
2021
Q1
$24K Hold
15,000
﹤0.01% 442
2020
Q4
$3K Hold
15,000
﹤0.01% 419
2020
Q3
$2K Buy
+15,000
New +$2.07K ﹤0.01% 389

Other funds holding ZOM

Sequoia Financial Advisors's ZOM Position: Q1 2025 in Review

Sequoia Financial Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 214,949 shares — an estimated $25.8K sold.

Sequoia Financial Advisors first reported a position in ZOM in Q3 2020 and held it in 13 quarters. The position peaked at $43K in Q4 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Sequoia Financial Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Sequoia Financial Advisors sold 214,949 Zomedica Corp. shares in Q1 2025, an estimated $25.8K.
  • Sequoia Financial Advisors first reported a position in Zomedica Corp. in Q3 2020 and held it in 13 quarters.
  • Sequoia Financial Advisors's Zomedica Corp. position peaked at $43K in Q4 2023.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Sequoia Financial Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.